IP Verse

Diagnostic Methods For T Cell Therapy - EP3302507B1

PatentPatent Analysis

EP3302507

KITE PHARMA
Application Number
EP16800846A
Filing Date
May 27, 2016
Status
Granted And Under Opposition
Jan 20, 2023
Grant Date
Feb 22, 2023
External Links
Slate, Register, Google Patents

Bibliography

The patent EP3302507B1 was granted to Kite Pharma on Feb 22, 2023 following the initial filing on May 27, 2016 under the application number EP16800846A . The current legal status of the patent is Granted And Under Opposition.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

BOULT WADE TENNANTNov 22, 2023ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents